Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): A novel interface in the allergic process

Ido Bachelet, Ariel Munitz, David Mankuta, Francesca Levi-Schaffer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Mast cells have critical effector functions in various immune reactions. In allergic inflammation, mast cells interact with tissue-infiltrating eosinophils, forming a regulatory unit in the late and chronic phases of the allergic process. However, the pathways and molecules within this unit are still largely undefined. Here, we show that human mast cells and eosinophils express DNAX accessory molecule 1 (DNAM-1, CD226) and its ligand Nectin-2 (CD112). CD226 synergizes with FcεRI on mast cells, and its engagement augments degranulation through a pathway involving Fyn, linker of activation of T-cells, phospholipase C γ2, and CD18. This pathway is subject to negative interference by inhibitory receptors and is completely inhibited by linking IgE with IRp60 (CD300a) using a bispecific antibody. Moreover, blocking CD112 expressed on eosinophils using neutralizing antibodies normalized the hyperactivity resulting from IgE-dependent activation of mast cells co-cultured with eosinophils. Our findings demonstrate a novel interface between these two effector cells, implicating relevance for in vivo allergic states. Moreover, costimulatory responses might be a critical component in allergic reactions and may therefore become novel targets for anti-allergic therapy.

Original languageAmerican English
Pages (from-to)27190-27196
Number of pages7
JournalJournal of Biological Chemistry
Issue number37
StatePublished - 15 Sep 2006


Dive into the research topics of 'Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): A novel interface in the allergic process'. Together they form a unique fingerprint.

Cite this